Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5982
    -0.0024 (-0.40%)
     
  • NZD/EUR

    0.5537
    -0.0005 (-0.10%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    82.92
    +1.57 (+1.93%)
     
  • GOLD

    2,239.80
    +27.10 (+1.22%)
     
  • NASDAQ

    18,255.79
    -25.05 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,776.19
    +16.11 (+0.04%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • NZD/JPY

    90.4810
    -0.2990 (-0.33%)
     

Company News For Mar 19, 2019

Incyte (INCY) is slated to report first-quarter results on Apr 30. Investors will primarily focus on Jakafi sales and pipeline updates.
  • Overstock.com, Inc.’s OSTK shares dipped 5.3% after the company reported fourth quarter 2018 loss per share of $1.15, wider than the Zacks Consensus Estimate of a loss of $0.67 a share

  • Fidelity National Information Services, Inc.’s FIS shares declined 0.7% after the company announced that it was buying Worldpay, Inc. WP in a cash-and-stock deal worth $43 billion

  • Shares of Edwards Lifesciences Corporation EW surged 6.2% after the company reported positive results from studies related to its non-invasive heart valve replacement systems

  • Shares of Dermira, Inc. DERM rallied 82.2% after the company announced positive results from the mid-stage trial of its treatment for moderate-to-severe atopic dermatitis


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Overstock.com, Inc. (OSTK) : Free Stock Analysis Report
 
Edwards Lifesciences Corporation (EW) : Free Stock Analysis Report
 
Dermira, Inc. (DERM) : Free Stock Analysis Report
 
Fidelity National Information Services, Inc. (FIS) : Free Stock Analysis Report
 
Vantiv, Inc. (WP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research